Tumor Suppressors—Retinoblastoma Genetics Retinoblastoma in children most commonly results from mutation in which class of gene?
-
AKinase (constitutively active growth-promoting enzyme)
-
BTumor suppressor (loss of RB1 function)
-
CCyclin (overexpressed cell-cycle activator)
-
DViral gene (introduced by an oncogenic virus)
-
EG-protein–coupled receptor that stimulates cAMP
Answer
Correct Answer: Tumor suppressor (loss of RB1 function)
Explanation
Introduction / Context:Retinoblastoma is a pediatric eye tumor that provided the classic model for tumor suppressor gene function and the “two-hit hypothesis.” The RB1 gene encodes the retinoblastoma protein (pRB), a negative regulator of the G1→S transition in the cell cycle. This item asks you to identify the gene class most directly implicated in retinoblastoma pathogenesis.
Given Data / Assumptions:
- RB1 loss leads to uncontrolled E2F activity and cell-cycle progression.
- Hereditary cases inherit one mutant RB1 allele and acquire a second somatic hit.
Concept / Approach:Decide whether the driver is activation of an oncogene or loss of a tumor suppressor. Retinoblastoma arises from biallelic inactivation of RB1, making it the prototypical tumor suppressor gene–driven cancer.
Step-by-Step Solution:
Step 1: Recall pRB function: inhibits E2F, restraining G1→S transition.Step 2: Loss of RB1 removes this brake, enabling proliferation.Step 3: Select “tumor suppressor (loss of RB1)” as the correct class.Verification / Alternative check:Knudson’s two-hit model was formulated from bilateral vs unilateral retinoblastoma data, consistent with tumor suppressor loss rather than oncogene activation alone.
Why Other Options Are Wrong:
- Kinase/cyclin activation are oncogene mechanisms but are not the hallmark initiating lesion in retinoblastoma.
- Oncogenic viruses are not the primary cause here.
- GPCR activation is not the canonical driver.
Common Pitfalls:Confusing oncogene gain-of-function with tumor suppressor loss-of-function; forgetting the two-hit requirement.
Final Answer:Tumor suppressor (loss of RB1 function)